| Shareholder | |||
|---|---|---|---|
| Juno Therapeutics, Inc. | 17.82% | 70.23M | |
| Bristol-Myers Squibb Company | 17.82% | 70.23M | |
| Syracuse Biopharma (Cayman) Ltd. | 12.90% | 48.51M | |
| Syracuse Biopharma (Cayman) II, Ltd. | 12.07% | 48.51M | |
| Li Yiping James | 6.98% | 29.04M | |
| Li Dan | 6.98% | 29.04M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of JW THERAP-B (02126) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

